Establishing the Optimal Ceftriaxone MIC for Predicting ESBL Production in Bloodstream Infections

2025/08/14 by Dariusz A Hareza, Yehudit Bergman, Emily Jacobs +5 · 1 voice
Immunology and Microbiology · Medicine · #Antibiotic Use and Resistance #Antibiotics Pharmacokinetics and Efficacy #Biosimilars and Bioanalytical Methods

paper · pdf · doi:10.1093/ofid/ofaf490

openalex publication_date 2025/08/14 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/29

Abstract

Dariusz A Hareza, Yehudit Bergman, Emily Jacobs, Amy J Mathers, Alan R Hauser, Sara E Cosgrove, Patricia J Simner, Pranita D Tamma; Establishing the Optima

Citations

• Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections

Discussions

• Establishing the Optimal Ceftriaxone MIC for Predicting ESBL Production in Bloodstream Infections ✅ Just Accepted #IDSky [bsky, 4 points, 0 comments]

Related

• Determining the Optimal Ceftriaxone MIC for Triggering Extended-Spectrum β-Lactamase Confirmatory Testing
• Conditional production of acyl-homoserine lactone-type quorum-sensing signals in clinical isolates of enterobacteria
• Detection of Favorable Oral Cephalosporin-Clavulanate Interactions by In Vitro Disk Approximation Susceptibility Testing of Extended-Spectrum-Beta-Lactamase-Producing Members of the Enterobacteriaceae
• Optimizing antimicrobial therapy. A method for antimicrobial drug me evaluation
• Inferring Amoxicillin-Clavulanate Susceptibility From Ampicillin-Sulbactam Susceptibility Against Common Enterobacterales Species